Showing 423 results

Filters Content type: News, Editors' picks, About HIV Topic: PrEP policies & guidelines

Health service and government policies on the licensing, provision and reimbursement of oral pre-exposure prophylaxis (PrEP). Expert guidelines, based on research evidence, to help clinicians provide care to PrEP users.

PrEP policies & guidelines

PrEP Advocates Call New Gilead Sciences Patent Suit Against HHS a 'Distraction'

Editor's pick
TheBody
5 May 2020
Pharmaceutical industry

Gilead ratchets up its Truvada patent fight with U.S. in new breach-of-contract lawsuit

Editor's pick
FiercePharma
28 April 2020
PrEP policies & guidelines

No more subsidised Truvada for Australians, but there are alternatives

Editor's pick
Star Observer
2 April 2020
PrEP policies & guidelines

England: Building on the PrEP victory

Editor's pick
The Lancet (editorial)
27 March 2020
PrEP policies & guidelines

UNAIDS welcomes government’s decision to make PrEP routinely available across England

Editor's pick
UNAIDS
17 March 2020
PrEP policies & guidelines

Statement in response to the Department of Health and Social Care fully-funding roll out of PrEP

Editor's pick
Sophia Forum
16 March 2020
PrEP policies & guidelines

HIV drug PrEP to be available across England

Editor's pick
Department of Health and Social Care
16 March 2020
PrEP policies & guidelines

PrEPster applauds England PrEP decision

Editor's pick
Prepster
15 March 2020
PrEP policies & guidelines

Statement in response to Department of Health and Social Care fully-funding roll-out of PrEP

Editor's pick
National AIDS Trust
15 March 2020
PrEP policies & guidelines

Far fewer people would get PrEP in the US if generic TDF/FTC is replaced with Descovy (TAF/FTC), cost-effectiveness study finds

News
9 March 2020
PrEP policies & guidelines

England: Charity questions readiness for PrEP to be routinely available by April 2020

Editor's pick
Pharmaceutical Journal
26 February 2020
PrEP programmes & uptake

Uncertainties over PrEP created by NHS England's IMPACT trial "unethical"

News
25 February 2020
The search for an HIV prevention vaccine

HIV vaccine trial failure is a “wake up call” for southern Africa, say researchers

News
24 February 2020
PrEP policies & guidelines

If I can be protected against HIV, others should be too

Editor's pick
The Guardian
23 February 2020
Pharmaceutical industry

Gilead loses again in PrEP patent fight with HHS, sending dispute to federal court

Editor's pick
Fierce Pharma
22 February 2020
PrEP policies & guidelines

Malta: PrEP is not just a health issue but an educational one

Editor's pick
Malta Independent
17 February 2020
PrEP policies & guidelines

A drug can stop HIV infection – so why isn't it available on the NHS in England?

Editor's pick
The Guardian
17 February 2020
PrEP policies & guidelines

England and Wales PrEP warning: We're running out of money

Editor's pick
Gay Star News
12 February 2020
Pharmaceutical industry

Gilead says 'Step up for PrEP' in Descovy's first HIV prevention campaign

Editor's pick
FiercePharma
11 February 2020
Side effects

PrEP in pregnancy: safe, but many unanswered questions

News
7 February 2020
Pharmaceutical industry

Gilead loses challenge to two patents over an HIV prevention pill

Editor's pick
STAT
6 February 2020
PrEP programmes & uptake

South African government plans massive PrEP rollout

Editor's pick
Spotlight
5 February 2020
PrEP policies & guidelines

Dear Matt Hancock. No more grandiose gestures, we demand action on PrEP in the UK

Editor's pick
PinkNews
31 January 2020
PrEP programmes & uptake

Australian researchers present two possible ‘PrEP cascades’ that could be used to measure uptake

News
31 January 2020